See Federal Register Notice http://edocket.access.gpo.gov/2010/pdf/2010-19283.pdf
Note: In the comments below a reader addresses CRE’s continued concern about who is writing the TPSAC reports. If this were any proceeding other than tobacco, we seriously doubt that FDA could ignore established rules governing the conduct of FACA committees.
It appears that CRE’s continued statements highlighting the need for Committee members, not FDA, to write TPSAC reports may be falling on deaf ears.
CRE will explore a more powerful intervention other than notice and comment.